By Mill Chart
Last update: Jul 21, 2025
NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) was identified by our Decent Value stock screener as a candidate with strong fundamentals and an attractive valuation. The company, a leader in diabetes and obesity care, combines solid profitability with reasonable growth prospects while trading at a discount relative to industry peers.
NVO’s valuation metrics suggest the stock may be trading below its intrinsic value:
The company excels in profitability, with key strengths including:
While NVO maintains a strong solvency position, liquidity metrics show some concerns:
Revenue and earnings growth remain supportive:
Our Decent Value screener lists more stocks with similar characteristics. For a deeper look, review the full fundamental report for NVO.
This is not investing advice! The article highlights observations at the time of writing, but you should always conduct your own analysis before making investment decisions.
NYSE:NVO (7/23/2025, 1:05:09 PM)
70.3088
+3.53 (+5.28%)
Find more stocks in the Stock Screener